- 関
- administration schedule、dosage regimen、dosing regimen、regimen
WordNet
- (medicine) a systematic plan for therapy (often including diet) (同)regime
- plan for an activity or event; "Ive scheduled a concert next week"
- an ordered list of times at which things are planned to occur
- make a schedule; plan the time and place for events; "I scheduled an exam for this afternoon"
- planned or scheduled for some certain time or times; "the scheduled meeting"; "the scheduled flights had to be cancelled because of snow"
- setting an order and time for planned events (同)programming, programing
PrepTutorEJDIC
- 摂生,養生[法],健康法,食事療法
- 《おもに米》(列車などの)『時間表』,時刻表;(授業などの)時間割り / (時間によって定めた)『予定』,計画,スケジュール / (料金などの)一覧表,細目表 / …‘の'スケジュール(時間表,一覧表)を作る;…‘を'スケジュールに入れる / 《しばしば受動態で》…‘を'予定する
- 〈C〉《通例a~》1回分の投薬量 / 〈U〉《まれ》投薬
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 小児や青年への定期予防接種:概要standard immunizations for children and adolescents overview [show details]
… refuse childhood vaccines is discussed separately. Preterm infants – The routine immunization schedule, dose, intervals, and contraindications/precautions are the same for preterm infants (born at <37 weeks …
- 2. 非プラチナ製剤ベースの癌化学療法の神経学的合併症の概要overview of neurologic complications of non platinum cancer chemotherapy [show details]
…the mean total dose at the onset of grade 2 neurotoxicity was 715 mg/m2 . Weekly paclitaxel is less myelosuppressive than an every three-week schedule, thereby allowing increased dose intensity. Whether …
- 3. 頭頚部癌への根治的放射線治療:照射線量および線量分割の注意点definitive radiation therapy for head and neck cancer dose and fractionation considerations [show details]
…formal clinical trial. Daily radiation therapy (RT) using a dose of 2 Gy to gross tumor on a five-days-per-week schedule to a total dose of 66 to 70 Gy in seven weeks is the standard treatment regimen …
- 4. HER2陰性乳癌に対する補助化学療法adjuvant chemotherapy for her2 negative breast cancer [show details]
… demonstrated that paclitaxel is more effective when used in a lower, but dose-dense fashion compared with a higher dosage on a three-week schedule (80 mg/m2 every week x 12 versus 175 mg/m2 every three …
- 5. 成人の炎症性腸疾患患者へのブデソニド療法の概要overview of budesonide therapy for adults with inflammatory bowel disease [show details]
…specific drug interactions, refer to the program included in UpToDate. The starting dose and subsequent tapering schedule of the oral budesonide formulations (eg, controlled ileal release form, budesonide …
English Journal
- Optimal dosage and dwell time of ethanol lock therapy on catheters infected with Candida species.
- Oncü S.Author information Adnan Menderes University Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 09100 Aydin, Turkey. Electronic address: soncu@dr.com.AbstractBACKGROUND & AIMS: Anti-infective lock therapy is a treatment strategy in conjunction with systemic antifungal agents for the treatment of intravascular catheter infections caused by fungi. In this study, the optimal dosage and dwell time of ethanol lock solution (ELS) effective against catheters infected by Candida species were assessed.
- Clinical nutrition (Edinburgh, Scotland).Clin Nutr.2014 Apr;33(2):360-2. doi: 10.1016/j.clnu.2013.04.014. Epub 2013 Apr 27.
- BACKGROUND & AIMS: Anti-infective lock therapy is a treatment strategy in conjunction with systemic antifungal agents for the treatment of intravascular catheter infections caused by fungi. In this study, the optimal dosage and dwell time of ethanol lock solution (ELS) effective against catheter
- PMID 23672805
- Influence of adding etravirine on complexity index and patients' perceived complexity.
- Calvo-Cidoncha E1, González-Bueno J, Almeida-González CV, Morillo-Verdugo R.Author information 1Pharmacy Department, Valme University Hospital, Seville, Spain.AbstractWHAT IS KNOWN AND OBJECTIVE: Adherence to highly active antiretroviral treatment (HAART) is an important predictive factor of treatment outcome. Medication regimen complexity can be one of the main causes of non-adherence. Thus, treatment simplification is a key strategy in the development of antiretroviral therapy. The aim of this study was to determine the influence of adding etravirine on complexity index and patients' perceived complexity of their treatment regimen.
- Journal of clinical pharmacy and therapeutics.J Clin Pharm Ther.2014 Apr;39(2):154-7. doi: 10.1111/jcpt.12120. Epub 2013 Dec 23.
- WHAT IS KNOWN AND OBJECTIVE: Adherence to highly active antiretroviral treatment (HAART) is an important predictive factor of treatment outcome. Medication regimen complexity can be one of the main causes of non-adherence. Thus, treatment simplification is a key strategy in the development of antire
- PMID 24372048
- Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation.
- Vélez de Mendizábal N1, Strother RM, Farag SS, Broxmeyer HE, Messina-Graham S, Chitnis SD, Bies RR.Author information 1Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, 1001 W. 10th Street W7138, Indianapolis, IN, 46202, USA, nvelezde@iu.edu.AbstractBACKGROUND AND OBJECTIVES: Dipeptidyl peptidase-4 (DPP4) inhibition is a potential strategy to increase the engraftment rate of haematopoietic stem/progenitor cells. A recent clinical trial using sitagliptin, a DPP4 inhibitor approved for type 2 diabetes mellitus, has been shown to be a promising approach in adults with haematological malignancies after umbilical cord blood (UCB) haematopoietic cell transplantation (HCT). On the basis of data from this clinical trial, a semi-mechanistic model was developed to simultaneously describe DPP4 activity after multiple doses of sitagliptin in subjects with haematological malignancies after a single-unit UCB HCT.
- Clinical pharmacokinetics.Clin Pharmacokinet.2014 Mar;53(3):247-59. doi: 10.1007/s40262-013-0109-y.
- BACKGROUND AND OBJECTIVES: Dipeptidyl peptidase-4 (DPP4) inhibition is a potential strategy to increase the engraftment rate of haematopoietic stem/progenitor cells. A recent clinical trial using sitagliptin, a DPP4 inhibitor approved for type 2 diabetes mellitus, has been shown to be a promising a
- PMID 24142388
Japanese Journal
- 進行再発乳がんに対するエリブリンメシル酸塩単独療法の投与量減量法と投与間隔延長法の臨床効果を比較した後方視的研究
- 進行再発乳癌に対するエリブリンメシル酸塩単独療法の投与量減量法と投与間隔延長法の臨床効果を比較した後方視的研究
- 心臓血管外科手術における自己血及び同種血輸血の現状と適正準備方法の検討
Related Pictures
★リンクテーブル★
[★]
- (食事などの)養生規則、養生計画。(薬の)処方計画、投薬計画
- 関
- action、administration schedule、cure、dosage regimen、dosage schedule、dosing regimen、remedy、therapeutic、therapy
[★]
- 英
- dosing regimen、dosage regimen、administration schedule、dosage schedule、regimen
- 関
- 措置、養生、療法、レジメン
[★]
- 関
- administration schedule、dosage regimen、dosage schedule、regimen
[★]
- 関
- dosage regimen、dosage schedule、dosing regimen、regimen
[★]
- 関
- dose、drug product、formulation、ID、injected dose、input、preparation、therapeutic dose
[★]
- 関
- appointment、destine、plan、predetermine、prospective